Skip to main content
Future Medicine Co., Ltd. logo

Future Medicine Co., Ltd. — Investor Relations & Filings

Ticker · 341170 ISIN · KR7341170009 KO Manufacturing
Open in API
Filings indexed 96 across all filing types
Latest filing 2026-05-18 Investor Presentation
Country KR South Korea
Listing KO 341170

About Future Medicine Co., Ltd.

http://futuremedicine.co.kr/

Future Medicine Co., Ltd. is a new drug development company specializing in nucleoside-based synthetic drugs. The company focuses on creating therapeutics for diseases with high unmet medical needs, particularly in antiviral and anticancer applications. Its primary pipeline candidate, FM101, is an anti-inflammatory and anti-fibrotic agent being investigated for the treatment of conditions such as non-alcoholic steatohepatitis (NASH), diabetic nephropathy, and primary biliary cholangitis (PBC). The company has also conducted research and filed patents for therapeutics related to coronaviruses.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Investor Presentation Classification · 92% confidence The document is a notice announcing the scheduling and details of a company’s investor relations presentation (기업설명회 IR), including date, time, location, agenda, and IR materials posting. It is not the full presentation itself but is clearly an IR event announcement. According to the classification definitions, this fits best under Investor Presentation (IP).
2026-05-18 Korean
대표이사변경
Board/Management Information Classification · 92% confidence The document is an official announcement of changes in the company’s representative directors (CEO), detailing the outgoing and incoming persons, dates of board resolutions, reasons, and biographical details. This matches the definition of Board/Management Information (MANG).
2026-05-12 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 89% confidence The document is the official results of an Extraordinary Shareholders’ Meeting (임시주주총회 결과), listing meeting date, voting date, agenda items, vote counts and approval status. This fits the category for Declaration of Voting Results & Voting Rights Announcements.
2026-05-12 Korean
[기재정정]주요사항보고서(유상증자결정)
Capital/Financing Update Classification · 95% confidence The document is titled '주요사항보고서(유상증자결정)' which translates to 'Material Fact Report (Decision on Paid-in Capital Increase)'. It details changes in the schedule for payment and listing dates related to a capital increase, specifics about the new shares, the purpose of the capital raise, and information about the third-party allotment. The content focuses on the announcement of a financing event (capital increase) including share issuance details, pricing, and shareholder changes. There are no financial statements or comprehensive financial performance data, so it is not an Annual Report or Interim Report. It is not a regulatory certification or a report publication announcement but a substantive update on capital raising. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length (6170 characters) supports it being a detailed announcement rather than a brief notice.
2026-04-30 Korean
[기재정정]주요사항보고서(유상증자결정)
Capital/Financing Update Classification · 100% confidence The document is titled '주요사항보고서(유상증자결정)' which translates to 'Material Information Report (Decision on Paid-in Capital Increase)'. It details changes to a previously submitted report about a capital increase, including revised payment dates, listing dates, and specifics about the issuance of new shares. The content includes detailed information about the capital increase method, share types, pricing, and the purpose of the capital raise. This is a regulatory announcement about a financing event, specifically a paid-in capital increase (유상증자). It is not a full financial report, earnings release, or management discussion, but an update on financing activity. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is sufficient and contains substantive details about the financing event, not just a brief announcement or a report publication notice.
2026-04-30 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 93% confidence The document is a ‘주주총회 소집공고’ (notice of convocation of the 12th extraordinary general meeting of shareholders) containing the meeting date, agenda items (director election), candidate biographies, and supporting information sent to shareholders to solicit votes. This fits the Proxy Solicitation & Information Statement category.
2026-04-27 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.